摘要
本文分析了３３例ＡＦＰ阴性肝癌的临床病理表现及预后，并和１０３例ＡＦＰ阳性肝癌相对照。结果表明：ＡＦＰ阴性肝癌患者血清ＨＢｓＡｇ阳性较低（６６．７％对８４．５％，Ｐ＜０．０５），临床腹痛症状少（３０．３％对５０．５％，Ｐ＜０．０５），Ⅱ期病人较多（９３．９％对７３．８％，Ｐ＜０．０５），大于５ｃｍ肿块少（５１．５％对７２．８％，Ｐ＜０．０５），术后１年、３年存活率高（５７．６％对３１．１％，Ｐ＜０．０１）、（２４．２％对８．７％，Ｐ＜０．０５），而患者性别、发病年龄、体征、肿瘤部位、数目、生长方式及细胞分化等，则和对照组相似。结合文献，对ＡＦＰ阴性肝癌的诊断也作了讨论。
The clinicopathological charcteristics of 33 a-fetopretein(AFP) negative hepatocellular carcinoma(HCC) were analysed and compaired with 103 AFP positive HCC.The results showed that serum HBsAg positive rate was lower(66.7 % to 84.5 %,P<0.05),abdominal pain was less serious (30.3% to 50.5%,P<0.05),patients of stage II were more(93.9% to 73.8%,P<0.05),over 5cm lesions were fewer (51.5% to 72.8%,P<0.05),1 or 3 year survival rate after operation was higher(57.6% to 31.1%,P<0.01),(24.2 % to 8.7%,P<0.05) in AFP negative HCC than those in control.The patient's sex,age,signs,tumor's site,number,growing pattern,differentiation had no significant difference between the two groups.Diagnosis of AFP negative HCC is also disczussed in this paper.
出处
《河南肿瘤学杂志》
1996年第2期101-103,共3页
Henan Journal of Oncology
关键词
甲胎蛋白
肝癌
病理
预后
α-fetoprotein,liver cancer,clinicopathology,prognosis
